FCPR-16

N/A

Report date: 2023/04/02 14:28:17

Base Information

Drug NameFCPR-16
Drug Alias NameFCPR-16
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesLansheng Biomedical (Suzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLansheng Biomedical (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsStroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A